All public logs

Combined display of all available logs of Beacon. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).

13:15, 4 December 2023 Francine talk contribs created page Trainings: UCT Trainings (University Cancer Center Frankfurt) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to University Cancer Center Frankfurt page '''Primary purpose:''' To promote interdisciplinary training for healthcare professionals, organize further education, and provide information events for patients, relatives, and the general public. '''Target audience:''' Healthcare professionals, students, nurses, doctors, scientists, patients and the general public. '''Access Information:''' Information [https:...")
13:13, 4 December 2023 Francine talk contribs created page Experts (University Cancer Center Frankfurt) (Created page with "{{forproviders}} Go back to University Cancer Center Frankfurt page '''[https://www.uct-frankfurt.de/ueber-uns/onkologisches-zentrum/universitaetsklinikum.html Breast Center]''' '''[https://www.uct-frankfurt.de/ueber-uns/onkologisches-zentrum/universitaetsklinikum.html Children's Oncology Center]''' '''[https://www.uct-frankfurt.de/ueber-uns/onkologisches-zentrum/universitaetsklinikum.html Gynecological Cancer]''' '''[https://www.uct-frankfurt.de/ueber-uns/onkolo...")
13:11, 4 December 2023 Francine talk contribs created page Trials (University Cancer Center Frankfurt) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to University Cancer Center Frankfurt page '''NCTID''': NCT04821622 '''Title''': Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC '''Study Summary''': The purpose of the study is to evaluate the safety and efficacy of talazoparib in combination with enzalutamide compared with placebo in combination with enzalutamide in participants with DDR-deficient mCSPC. '''Sponsor''': Pfiz...")
13:06, 4 December 2023 Francine talk contribs created page Trials (Charité Comprehensive Cancer Center) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Charité Comprehensive Cancer Center page '''NCTID''': NCT02951767 '''Title''': A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 1) '''Study Summary''': This Phase II, single-arm study is designed to evaluate the effect of atezolizumab treatment in participants with locally advanced or metastatic urothelial bladder cancer. Participants will...")
12:48, 4 December 2023 Francine talk contribs created page Trials (National Cancer Center Dresden) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to National Cancer Center Dresden page '''NCTID''': NCT03430843 '''Title''': A Study of Tislelizumab (BGB-A317) Versus Chemotherapy as Second Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma '''Study Summary''': The purpose of this study is to evaluate the efficacy and safety of tislelizumab as second line treatment in participants with advanced unresectable/metastatic ESC...")
12:37, 4 December 2023 Francine talk contribs created page Trials (Institut Sainte Catherine) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Institut Sainte Catherine page '''NCTID''': NCT01300143 '''Title''': Association of Conformational High-dose Radiotherapy and of Hyperselective Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma '''Study Summary''': Indication : Hepatocellular carcinoma, maximum size 9 cm, with single or multiple nodes whose total tumor mass can technically be irradiated, non-resectable, and...")
12:28, 4 December 2023 Francine talk contribs created page Trials (Centre Henri Becquerel) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Centre Henri Becquerel page '''NCTID''': NCT04712097 '''Title''': A Study Evaluating the Efficacy and Safety of Mosunetuzumab in Combination With Lenalidomide in Comparison to Rituximab in Combination With Lenalidomide With a US Extension of Mosunetuzumab in Combination With Lenalidomide in Participants With Follicular Lymphoma '''Study Summary''': This study will evaluate the efficacy and safety of...")
23:59, 3 December 2023 Francine talk contribs created page Trials (Georges-François Leclerc Cancer Center) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Georges-François Leclerc Cancer Center page '''NCTID''': NCT02947685 '''Title''': Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer '''Study Summary''': The primary objective of this study is to demonstrate that the combination of palbociclib with anti-HER2 therapy plus endocrine therapy is superior to anti-HER2-based therapy plus endocrin...")
23:52, 3 December 2023 Francine talk contribs created page Trials (Institut Godinot) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Institut Godinot page '''NCTID''': NCT03943667 '''Title''': Gemcitabine and Paclitaxel vs Gemcitabine Alone After FOLFIRINOX Failure in Metastatic Pancreatic Ductal Adenocarcinoma '''Study Summary''': This study aims to evaluate whether the combination of gemcitabine and paclitaxel allows to improve the overall survival compared to gemcitabine alone, in patients with metastatic Pancreatic Ductal Aden...")
23:43, 3 December 2023 Francine talk contribs created page Trials (Institut du Cancer de Montpellier) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Institut du Cancer de Montpellier page '''NCTID''': NCT00875667 '''Title''': A Study to Determine the Efficacy of Lenalidomide Versus Investigator’s Choice in Patients With Relapsed or Refractory Mantle Cell Lymphoma (MCL) '''Study Summary''': To evaluate the safety and efficacy of lenalidomide versus investigator choice in patients with relapsed or refractory mantle cell lymphoma. '''Sponsor''':...")
23:37, 3 December 2023 Francine talk contribs created page Trials (Comprehensive Cancer Center Jean Perrin) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Comprehensive Cancer Center Jean Perrin page '''NCTID''': NCT01491737 '''Title''': A Study of Pertuzumab in Combination With Trastuzumab Plus an Aromatase Inhibitor in Participants With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive and Hormone Receptor-Positive Advanced Breast Cancer '''Study Summary''': This randomized, open-label, two-arm, multi-center, Phase II study will eva...")
23:30, 3 December 2023 Francine talk contribs created page Trials (Cancer Institute Strasbourg Europe) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Cancer Institute Strasbourg Europe page '''NCTID''': NCT04717414 '''Title''': An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Subjects With Myeloproliferative Neoplasm-Associated Myelofibrosis on Concomitant JAK2 Inhibitor Therapy and Who Require Red Blood Cell Transfusions '''Study Summary''': The purpose of this Phase 3 study is to evaluate the efficacy and safety of Luspa...")
23:15, 3 December 2023 Francine talk contribs created page Trials (Eugène Marquis Cancer Centre) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Eugène Marquis Cancer Centre page '''NCTID''': NCT02444000 '''Title''': gliomasPCV Only in 1p/19q Codeleted Anaplastic Gliomas '''Study Summary''': Patients with 1p/19q-codeleted anaplastic gliomas treated with RT + PCV are at risk of neurocognitive deterioration. Treating these patients with PCV alone (could reduce the risk of neurocognitive deterioration without impairing overall survival. '''Sp...")
23:06, 3 December 2023 Francine talk contribs created page Trials (Institut de Cancérologie de lOuest (ICO) - Integrated Center for Oncology) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Institut de Cancérologie de lOuest (ICO) - Integrated Center for Oncology page '''NCTID''': NCT03943667 '''Title''': Gemcitabine and Paclitaxel vs Gemcitabine Alone After FOLFIRINOX Failure in Metastatic Pancreatic Ductal Adenocarcinoma '''Study Summary''': This study aims to evaluate whether the combination of gemcitabine and paclitaxel allows to improve the overall survival compared to gemcitabine...")
23:03, 3 December 2023 Francine talk contribs created page Trials (Institut de Cancérologie de l'Ouest (ICO) - Integrated Center for Oncology) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Institut de Cancérologie de l'Ouest (ICO) - Integrated Center for Oncology page '''NCTID''': NCT03943667 '''Title''': Gemcitabine and Paclitaxel vs Gemcitabine Alone After FOLFIRINOX Failure in Metastatic Pancreatic Ductal Adenocarcinoma '''Study Summary''': This study aims to evaluate whether the combination of gemcitabine and paclitaxel allows to improve the overall survival compared to gemcitabin...")
22:57, 3 December 2023 Francine talk contribs created page Trials (APHP - Sorbonne Université - Institut Universitaire de Cancérologie(IUC)) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to APHP - Sorbonne Université - Institut Universitaire de Cancérologie(IUC) page '''NCTID''': NCT04622319 '''Title''': A Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05) '''Study Summary''': Patients with HER2-positive primary breast cancer (BC) who...")
22:16, 1 December 2023 Francine talk contribs created page Trials (Centre François Baclesse) (Created page with "'''NCTID''': NCT01827943 '''Title''': Phase II Evaluating Efficacy of Temsirolimus in 2 Line Therapy for Patients With Advanced Bladder Cancer '''Study Summary''': In the absence of standard treatment in this indication, this test evaluates a new drug type targeted therapy in this indication, evaluating its efficacy in terms of tumor response and survival. '''Sponsor''': Institut Bergonié '''Intervention''': Temsirolimus '''Start Date''': 2009-06 '''Last Updated''...")
22:10, 1 December 2023 Francine talk contribs created page Trials (University Cancer Institute Toulouse-Oncopole) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to University Cancer Institute Toulouse-Oncopole page '''NCTID''': NCT06112314 '''Title''': IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301) '''Study Summary''': This is a phase 3, randomized, controlled study of IMC-F106C plus nivolumab compared to standard nivolumab regimens in HLA-A*02:01-positive participants with previously untreated advanced mel...")
22:04, 1 December 2023 Francine talk contribs created page Trials (Institut Paoli-Calmettes) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Institut Paoli-Calmettes page '''NCTID''': NCT04070443 '''Title''': Safety and Efficacy of Ponatinib Followed by Imatinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase '''Study Summary''': The investigators hypothesize that, in newly diagnosed de novo chronic phase CML patients, an induction treatment with ponatinib for 6 months should increase the rate of patients reaching a stable...")
21:58, 1 December 2023 Francine talk contribs created page Trials (Institut Curie) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Institut Curie page '''NCTID''': NCT03875573 '''Title''': Neo-adjuvant Chemotherapy Combined With Stereotactic Body Radiotherapy to the Primary Tumour +/- Durvalumab, +/- Oleclumab in Luminal B Breast Cancer: '''Study Summary''': Neo-CheckRay is a multicenter, open-label phase II study that randomizes luminal B breast cancer subjects candidate for neo-adjuvant chemotherapy in a 1:1:1 ratio in 3 arms:...")
21:52, 1 December 2023 Francine talk contribs created page Trials (Léon Bérard Center) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Léon Bérard Center page '''NCTID''': NCT01222767 '''Title''': Study of Zalypsis® (PM00104) in Patients With Unresectable Locally Advanced and/or Metastatic Ewing Family of Tumors (EFT) Progressing After at Least One Prior Line of Chemotherapy '''Study Summary''': This is a phase II Multicenter, Open-label, Clinical and Pharmacokinetic Study of Zalypsis® (PM00104) in Patients with Unresectable Loc...")
21:28, 1 December 2023 Francine talk contribs created page Trials (Oulu University Hospital) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Oulu University Hospital page '''NCTID''': NCT04607421 '''Title''': A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer '''Study Summary''': The purpose of this study is to evaluate two study medicines (encorafenib plus cetuximab) taken alone or together with standard chemotherapy for the potential treatment of colorectal c...")
21:22, 1 December 2023 Francine talk contribs created page Trials (Cancer Center of Kuopio University Hospital) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Cancer Center of Kuopio University Hospital page '''NCTID''': NCT04597125 '''Title''': Investigation of Radium-223 Dichloride (Xofigo), a Treatment That Gives Off Radiation That Helps Kill Cancer Cells, Compared to a Treatment That Inactivates Hormones (New Antihormonal Therapy, NAH) in Patients With Prostate Cancer That Has Spread to the Bone Getting Worse on or After Earlier NAH '''Study Summary''':...")
21:17, 1 December 2023 Francine talk contribs created page Trials (TAYS Cancer Centre Tampere University Hospital) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to TAYS Cancer Centre Tampere University Hospital page '''NCTID''': NCT04736706 '''Title''': A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012) '''Study Summary''': The goal of...")
21:11, 1 December 2023 Francine talk contribs created page Trials (Turku University Hospital Cancer Centre) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Turku University Hospital Cancer Centre page '''NCTID''': NCT03486873 '''Title''': Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587) '''Study Summary''': The purpose of this study is to evaluate the long-term safety and efficacy of pembrolizumab (MK-3475) in part...")
21:03, 1 December 2023 Francine talk contribs created page Trials (Institut Jules Bordet) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Institut Jules Bordet page '''NCTID''': NCT04966715 '''Title''': Inferior Epigastric Lymph Node (IELN) Basin as a Possible Systemic Metastatic Pathway of Colorectal Peritoneal Metastases '''Study Summary''': In this study, the investigators propose to systematically collect and analyse epigastric lymph nodes during complete cytureductive surgery in patients with colorectal carcinomatosis, in order to d...")
20:55, 1 December 2023 Francine talk contribs created page Trials (Masaryk Memorial Cancer Institute) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Masaryk Memorial Cancer Institute page '''NCTID''': NCT05603351 '''Title''': Prostate Cancer Screening With Abbreviated MRI Protocol '''Study Summary''': Prostate cancer is one of the most common malignancies in the male population with incidence and mortality rates comparable to breast cancer in women, but in contrast, a population screening program that would fulfill all the recommended criteria is n...")
20:52, 1 December 2023 Francine talk contribs created page Trials (Motol University Hospital) (Created page with "{{forpatients}} {{forresearchers}} {{forproviders}} Go back to Motol University Hospital page '''NCTID''': NCT02447666 '''Title''': Study With Azacitidine in Pediatric Subjects With Newly Diagnosed Advanced Myelodysplastic Syndrome (MDS) and Juvenile Myelomonocytic Leukemia (JMML) '''Study Summary''': Indication Treatment of pediatric subjects with newly diagnosed advanced myelodysplastic syndrome (MDS) or juvenile myelomonocytic leukemia (JMML) prior to hematop...")
20:50, 1 December 2023 Francine talk contribs created page Trials (Vejle Cancer Centre - The Patients’ Cancer Hospital part of Lillebaelt Hospital) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Vejle Cancer Centre – The Patients’ Cancer Hospital part of Lillebaelt Hospital page '''NCTID''': NCT05573022 '''Title''': Impact of a Patient Decision Aid Intervention '''Study Summary''': Studies evaluating decisions aids have used a wide range of outcome measures as well as formats and settings. Most studies have focused on patient decision aids used either within the consultation or delivered...")
20:49, 1 December 2023 Francine talk contribs created page Trials (The Patients’ Cancer Hospital part of Lillebaelt Hospital) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to The Patients’ Cancer Hospital part of Lillebaelt Hospital page '''NCTID''': NCT05573022 '''Title''': Impact of a Patient Decision Aid Intervention '''Study Summary''': Studies evaluating decisions aids have used a wide range of outcome measures as well as formats and settings. Most studies have focused on patient decision aids used either within the consultation or delivered pre-consultation, but t...")
20:47, 1 December 2023 Francine talk contribs created page Trials (Tartu University Hospital) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Tartu University Hospital page '''NCTID''': NCT04241185 '''Title''': Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Chemoradiotherapy (CRT) Versus CRT Alone in Muscle-invasive Bladder Cancer (MIBC) (MK-3475-992/KEYNOTE-992) '''Study Summary''': This study is designed to assess the antitumor efficacy and safety of pembrolizumab in combination with chemoradiotherapy (CRT) versus CRT a...")
20:45, 1 December 2023 Francine talk contribs created page Trials (North Estonia Medical Centre) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to North Estonia Medical Centre '''NCTID''': NCT02205047 '''Title''': Neoadjuvant Study Using Trastuzumab or Trastuzumab With Pertuzumab in Gastric or Gastroesophageal Junction Adenocarcinoma '''Study Summary''': The purpose of this study is to find out whether either trastuzumab or the combination of trastuzumab and pertuzumab with standard chemotherapy shows more activity against gastro-oesophageal aden...")
20:39, 1 December 2023 Francine talk contribs created page Trials (East Tallinn Central Hospital) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to East Tallinn Central Hospital Trials page '''NCTID''': NCT05152147 '''Title''': A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers '''Study Summary''': This study is being done to find out if zanidatamab, when given with chemotherapy plus or minus tislelizumab, is safe and works better t...")
20:38, 1 December 2023 Francine talk contribs created page Trials (East Tallinn Central Hospital Trials) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to East Tallinn Central Hospital Trials page '''NCTID''': NCT05152147 '''Title''': A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers '''Study Summary''': This study is being done to find out if zanidatamab, when given with chemotherapy plus or minus tislelizumab, is safe and works better t...")
20:05, 1 December 2023 Francine talk contribs created page Trials (Helsinki University Hospital Comprehensive Cancer Center) (Created page with "'''NCTID''': NCT04657991 '''Title''': A Clinical Trial of Three Study Medicines (Encorafenib, Binimetinib, and Pembrolizumab) in Patients With Advanced or Metastatic Melanoma '''Study Summary''': The purpose of this study is to learn about the effects of three study medicines (encorafenib, binimetinib, and pembrolizumab) given together for the treatment of melanoma that: * is advanced or metastatic (spread to other parts of the body); * has a certain type of abnormal...")
18:06, 30 November 2023 Francine talk contribs created page Trials (Kortrijk Cancer Centre AZ Groeninge) (Created page with "{{forresearchers}} Go back to Kortrijk Cancer Centre AZ Groeninge page Kortrijk Cancer Centre AZ Groeninge Trials")
13:51, 29 November 2023 Francine talk contribs created page Data Dictionary - National Registry of Childhood Cancer (RNCCR) (Created page with "=== Variables: === *CNP *Name *First name *Date of birth *Age *Sex *County *City *Address *Date of cancer diagnosis *Explication (reason for registering the diagnosis: hospitalization, death, biopsy, etc.) *Date of clinical onset *Date of relapse *Reason for reporting *Registration base (data source) *Tumor location *Topographical code *Laterality '''Histopathological/cytological examination:''' *Behavior *Morphological code *Degree *Cod ICC3 primary *Cod ICC3...")
13:43, 29 November 2023 Francine talk contribs created page Available Data Dictionary - National Registry of Childhood Cancer (RNCCR) (Created page with "=== Available Variables: === *CNP *Name *First name *Date of birth *Age *Sex *County *City *Address *Date of cancer diagnosis *Explication (reason for registering the diagnosis: hospitalization, death, biopsy, etc.) *Date of clinical onset *Date of relapse *Reason for reporting *Registration base (data source) *Tumor location *Topographical code *Laterality '''Histopathological/cytological examination:''' *Behavior *Morphological code *Degree *Cod ICC3 primary *...")
18:29, 28 November 2023 Francine talk contribs created page Data Dictionary: National Cancer Registry (Created page with "{| class="wikitable" |+ Data Dictionary |- | Address 1 |- | Address 2 |- | Address 3 |- | Address 4 |- | Address 5 |- | Address Id |- | Admission Type |- | Age At Incidence |- | Also Known As |- | Approximate Treatment Date |- | Care of Address |- | Clinical M |- | Clinical N |- | Clinical T |- | Clinical Tumour Size |- | Closed Date |- | Comment Date |- | Comment Id |- | Consultant |- | County Id |- | Date of Birth |- | Date of Death |- | Date of Incidence |- | Date of...")
18:17, 28 November 2023 Francine talk contribs created page Data Dictionary: Compilation: Department of Health Databases (CSO) (Created page with "{| class="wikitable" |+ Data on discharge, diagnostics, and procedures for inpatients |- | Age-Standardised Data for Principal Procedure |- | Age-Standardised Morbidity Rate for Principal Procedures |- | In-Patient and Daycase Principal Procedures and Average Length of Hospital Stay |- | Hospital Discharges of In-Patients, Daycases and Length of Stay (All Procedures) |- | Hospital Discharges of In-Patients, Daycases and Length of Stay (National Data - All Procedures) |-...")
17:10, 28 November 2023 Francine talk contribs created page Cancer Areas of Interest: I.Stat - Smoking Habits (Created page with "{| class="wikitable" |+ Cancers and Diagnoses ! ICD-10 Code !! Diagnoses |- | C00-C14 || Cancers of the oral cavity and pharynx |- | C15 || Cancer of the esophagus |- | C16 || Cancer of the stomach |- | C18-C21 || Cancers of the colon and rectum |- | C22 || Cancer of the liver |- | C25 || Cancer of the pancreas |- | C32 || Cancer of the larynx |- | C33-C34 || Cancers of the lung, bronchus, and trachea |- | C64-C65 || Cancers of the kidney and renal pelvis |- | C67 || Can...")
16:59, 28 November 2023 Francine talk contribs created page Cancer Areas of Interest: I.Stat - Causes of Death (Created page with "{| class="wikitable" |+ Malignant Neoplasms and Diagnoses ! ICD-10 Code !! Diagnoses |- | C00-C14 || Malignant neoplasm of lip, oral cavity, and pharynx |- | C15 || Malignant neoplasm of esophagus |- | C16 || Malignant neoplasm of stomach |- | C18-C21 || Malignant neoplasm of colon, rectum, and anus |- | C22 || Malignant neoplasm of liver |- | C25 || Malignant neoplasm of pancreas |- | C32 || Malignant neoplasm of larynx |- | C33-C34 || Malignant neoplasm of trachea, bro...")
15:03, 27 November 2023 Francine talk contribs created page Cancer Areas of Interest: Hospital Discharge Database (SDO) (Created page with "Source: [https://www.salute.gov.it/imgs/C_17_pubblicazioni_3277_allegato.pdf]. {| class="wikitable" |+ ICD-10 Codes and Diagnoses ! ICD-10 Code !! Diagnoses |- | C67 || Malignant bladder tumors |- | C50 || Malignant breast tumors |- | C77-C79 || Secondary malignant tumors (These codes represent secondary and unspecified malignant neoplasms) |- | D48 || Other and unspecified benign tumors (This is the code for neoplasms of uncertain or unknown behavior) |- | C34 || Malig...")
20:02, 24 November 2023 Francine talk contribs created page Cancer Areas of Interest: Cancer Registry (Created page with "{| class="wikitable" |+ ICD-10 Codes and Diagnoses ! ICD-10 Code !! Diagnosis |- | C00-C96 || Malignant neoplasms |- | C00 || Lip |- | C01-C14 || Malignant neoplasms of oral cavity and pharynx |- | C01 || Base of tongue |- | C15 || Malignant neoplasm of esophagus |- | C16 || Malignant neoplasm of stomach |- | C18 || Malignant neoplasm of colon |- | C19-C21 || Malignant neoplasms of rectosigmoid junction, rectum, and anus |- | C19 || Rectosigmoid junction |- | C22 || Mali...")
17:08, 24 November 2023 Francine talk contribs created page Cancer Areas of Interest: National Register of Cancer (RNC) (Created page with "All primary in situ and invasive tumors are recorded, except for non-melanoma skin cancers. For benign tumors or tumors with uncertain evolution, only the following tumors are recorded: *Benign tumors with uncertain evolution of the central nervous system (C70, C71 et C72) and intracerebral endocrine glands (C75.1 - C75.5); *Thymomas (C37.9); *Ovarian's borderline tumors (C56.9); *Invasive hydatidiform mole (placenta tumor) (C58.9); *pTa non-invasive papillary carcin...")
19:45, 22 November 2023 Francine talk contribs created page Data Dictionary: Oncobarómetro (Created page with "{| class="wikitable" |- | Subjective assessment of health status in the last twelve months | Type of healthy life | Health advice on various issues | Frequency in following health advice | Expectation of cure for a series of diseases | Areas of health research in which to make greater efforts in the future | Degree of severity of different health problems in Spain | Illness or situation that causes you the most fear | Reasons why an illness or situation makes you more af...")
17:08, 22 November 2023 Francine talk contribs created page Cancer Areas of Interest: Cancer Incidence in Portugal (Created page with "{| class="wikitable" |- ! ICD-10 Code !! Diagnoses |- | C00-C14 || Oral cavity and pharynx |- | C15-C26 || Peritoneum and digestive organs |- | C30-C39 || Respiratory system and intrathoracic organs |- | C40-C49 || Hematopoietic system and endothelial reticulum |- | C50-C58, C60-C63, C64-C68 || Genito-urinary organs |- | C50 || Breast |- | C69 || Eye and lacrimal gland |- | C70-C72 || Nervous system |- | C73-C75 || Endocrine glands |- | C47-C49 || Soft tissue |- | C77 ||...")
17:00, 22 November 2023 Francine talk contribs created page Cancer Areas of Interest: Cancer Survival and Incidence in the Central Region of Portugal (Created page with "Source: List is available on page 3 of the document [https://ron.min-saude.pt/media/2073/publicação-2010.pdf]. {| class="wikitable" |- ! ICD-10 Code !! Diagnoses |- | C00 || Lip |- | C01 || Base of tongue |- | C02 || Other and unspecified parts of the tongue |- | C03 || Gum |- | C04 || Floor of mouth |- | C05 || Palate |- | C06 || Other and unspecified parts of the mouth |- | C07 || Parotid gland |- | C08 || Other and unspecified major salivary glands |- | C09 || Tons...")
16:30, 22 November 2023 Francine talk contribs created page Cancer Areas of Interest: Cancer Incidence, Survival and Mortality in the Southern Region of Portugal (ISM) (Created page with "Source: The list can be checked on page 25 of the document [https://ron.min-saude.pt/media/2200/ror_sul_ism_2016_17.pdf]. {| class="wikitable" |- ! ICD-10 Code ! Diagnoses |- | C01 || Base of tongue |- | C02 || Other and unspecified parts of the tongue |- | C03 || Gum |- | C04 || Floor of mouth |- | C05 || Palate |- | C06 || Other and unspecified parts of the mouth |- | C07 || Parotid gland |- | C08 || Other and unspecified major salivary glands |- | C09 || Tonsil |- |...")
20:26, 21 November 2023 Francine talk contribs created page Cancer Areas of Interest: Hospital Morbidity Data Base (Created page with "{| class="wikitable" |- ! Cancer Areas of Interest |- | Lymphatic malignancies and/or other malignancies and/or neoplasms of uncertain behavior |- | Major procedures in BO for lymph nodes/hematopoietic organs or other |- | Malignant diseases of the ear, nose, mouth, throat, head/face |- | Malignant diseases of the kidney and/or urinary tract |- | Procedures in the kidney and/or urinary tract, due to malignant diseases |- | Malignant diseases of the male reproductive syst...")